Presence of Type I-F CRISPR/Cas systems is associated with antimicrobial susceptibility in Escherichia coli

Journal of Antimicrobial Chemotherapy

Volumn 72, Issue 8, 2017, Pages 2213-2218

  Aydin, Seyid ^a   Personne, Yoann ^a   Newire, Enas ^b   Laverick, Rebecca ^a   Russell, Oliver ^a   Roberts, Adam P ^b,c   Enne, Virve I ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE; RNA; ANTIINFECTIVE AGENT; BACTERIAL DNA;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CRISPR CAS SYSTEM; DNA SEQUENCE; ESCHERICHIA COLI; GENE SEQUENCE; GENETIC ASSOCIATION; MULTIDRUG RESISTANCE; NONHUMAN; REPLICON; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CHEMISTRY; CLASSIFICATION; DRUG EFFECTS; ESCHERICHIA COLI INFECTION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; PHYLOGENY; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY;

ANTI-BACTERIAL AGENTS; CRISPR-CAS SYSTEMS; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENE EXPRESSION PROFILING; HUMANS; PHYLOGENY; POLYMERASE CHAIN REACTION; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY;

EID: 85027195045     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkx137     Document Type: Article

References (26)

1. Marraffini LA, Sontheimer EJ. CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat Rev Genet 2010; 11: 181-90
2. Grissa I, Vergnaud G, Pourcel C. The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats. BMC Bioinformatics 2007; 8: 172
3. Horvath P, Barrangou R. CRISPR/Cas, the immune system of bacteria and archaea. Science 2010; 327: 167-70
4. Louwen R, Staals RH, Endtz HP et al. The role of CRISPR-Cas systems in virulence of pathogenic bacteria. MicrobiolMol Biol Rev 2014; 78: 74-88
5. Touchon M, Charpentier S, Clermont O et al. CRISPR distribution within the Escherichia coli species is not suggestive of immunity-associated diversifying selection. JBacteriol 2011; 193: 2460-7
6. Touchon M, Rocha EP. The small, slow and specialized CRISPR and anti-CRISPR of Escherichia and Salmonella. PLoS One 2010; 5: e11126
7. Makarova KS, Wolf YI, Alkhnbashi OS et al. An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol 2015; 13: 722-36
8. Westra ER, Pul U, Heidrich N et al. H-NS-mediated repression of CRISPRbased immunity in Escherichia coliK12canbe relievedby thetranscriptionactivator LeuO. MolMicrobiol 2010; 77: 1380-93
9. Almendros C, Guzman NM, Diez-Villasenor C et al. Target motifs affecting natural immunity by a constitutive CRISPR-Cas system in Escherichia coli. PLoS One 2012; 7: e50797
10. Magiorakos AP, Srinivasan A, Carey RB et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268-81
11. Enne VI, Delsol AA, Roe JM et al. Evidence of antibiotic resistance gene silencing in Escherichia coli. Antimicrob Agents Chemother 2006; 50: 3003-10
12. Clermont O, Christenson JK, Denamur E et al. The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. EnvironMicrobiol Rep 2013; 5: 58-65
13. WirthT, FalushD, LanRet al. Sex and virulence in Escherichia coli: anevolutionary perspective. MolMicrobiol 2006; 60: 1136-51
14. Clermont O, Dhanji H, Upton M et al. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 2009; 64: 274-7
15. Carattoli A, Bertini A, Villa L et al. Identification of plasmids by PCR-based replicon typing. JMicrobiolMethods 2005; 63: 219-28
16. Biswas A, Gagnon JN, Brouns SJ et al. CRISPRTarget: bioinformatic prediction and analysis of crRNA targets. RNA Biol 2013; 10: 817-27
17. Díez-Villaseñor C, Almendros C, García-Martínez J et al. Diversity of CRISPR loci in Escherichia coli. Microbiology 2010; 156: 1351-61
18. Woodford N, Carattoli A, Karisik E et al. Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob Agents Chemother 2009; 53: 4472-82
19. Riley LW. Pandemic lineages of extraintestinal pathogenic Escherichia coli. Clin Microbiol Infect 2014; 20: 380-90
20. Touchon M, Charpentier S, Pognard D et al. Antibiotic resistance plasmids spread among natural isolated Escherichia coli in spite of CRISPR elements. Microbiology 2012; 158: 2997-3004
21. Mathers AJ, Peirano G, Pitout JD. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev 2015; 28: 565-91
22. Adams-Sapper S, Diep BA, Perdreau-Remington F et al. Clonal composition and community clustering of drug-susceptible and-resistant Escherichia coli isolates from bloodstream infections. Antimicrob Agents Chemother 2013; 57: 490-7
23. Bengtsson S, Naseer U, Sundsfjord A et al. Sequence types and plasmid carriage of uropathogenic Escherichia coli devoid of phenotypically detectable resistance. J Antimicrob Chemother 2012; 67: 69-73
24. Golding GR, Persaud N, Levett PN et al. Characterization of Escherichia coli urinary tract infection isolates in remote northern Saskatchewan communities: the Northern Antibiotic Resistance Partnership. Diagn Microbiol Infect Dis 2012; 74: 242-7
25. Vogwill T, MacLean RC. The genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach. Evol Appl 2015; 8: 284-95
26. JiangW, Maniv I, Arain F et al. Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids. PLoS Genet 2013; 9: e1003844